CHICAGO — Lepodisiran, a small interfering RNA agent, lowered lipoprotein(a) levels at 180 days, with a reduction of more ...

A single dose of an experimental drug dramatically reduced levels of a deadly form of cholesterol, often thought to be ...

Quantbot Technologies LP acquired a new position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) during the ...

Researchers say they are exploring therapeutic options to block fatty acid accumulation and immunosuppressive signals between ...

The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...

Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...

Over the last three years, the FDA has approved six new hemophilia drugs, including three gene therapies. | Over the last ...

That process led to the group discovering a lasso peptide that exhibited broad-spectrum antibiotic activity and was effective ...

Supporters say consumers should be protected from unknowingly eating material from novel vaccines, which are similar to COVID ...

Two molecular control factors play a decisive role in what is known as splicing, the cutting and assembly of mature messenger ...

RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with ...

Alan Herbert, explores the understanding of genome information storage, and the significance of repetitive sequences called ...